A61P 19 - Drugs for skeletal disorders

Patents for A61P 19 - Drugs for skeletal disorders (81,981)
11/2009
11/10/2009	US7615564 Such as N5-[1-(2-chlorobenzyl)tetrahydro-1H-3-pyrrolyl]-5-isoquinolylamine; Rho kinase inhibitors; hypertension, asthma, angina pectoris, cerebrovascular contraction, peripheral circulatory disorder, threatened premature birth, glaucoma, vision disorders, autoimmune diseases, chronic renal failure
11/10/2009	US7615562 Such as 2-methyl-4-{5-[2-(2,2,6,6-tetramethyl-piperidin-4-ylamino)-pyrimidin-4-yl]-thiophen-2-yl}-butan-2-ol; tumor necrosis factor inhibitors; immunosuppressants; antiinflammatory agents
11/10/2009	US7615553 E.g., N,N-dimethyl,((5-(hydroxyaminocarbonyl)pyrimidin-2-yl)(piperazin-1,4-ylene)sulfonamide; bioavailability; oral administration; metabolic stability; side effect reduction; psoriasis; anticarcinogenic -proliferative, -arthritic, -inflammatory agent; gene therapy; genetic transcription potentiation
11/10/2009	US7615543 Complexes with C-reactive protein (CRP) molecules; rheumatoid arthritis, juvenile chronic (rheumatoid) arthritis, ankylosing spondylitis, psoriatic arthritis, systemic vasculitis, polymyalgia rheumatica, Reiter's disease, Crohn's disease and familial Mediterranean fever
11/10/2009	US7615341 Using allelic mutation on human chromosome 8 as diagnostic indicator of degenerative joint disease
11/10/2009	US7615207 Methods for treating irritable bowel syndrome
11/10/2009	CA2457952C Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h) one derivatives for neurodegenerative disorders
11/10/2009	CA2411572C 4,5-dihydro-thiazo-2-ylamine derivatives and their use as no-synthase inhibitors
11/10/2009	CA2378792C Aminothiazole derivatives and their use as crf receptor ligands
11/05/2009	WO2009134967A2 Use of nucleic acids with reduced pressure therapy
11/05/2009	WO2009134856A2 Pharmaceutical gallium compositions and methods
11/05/2009	WO2009134805A2 Antibodies to granulocyte-macrophage colony-stimulating factor
11/05/2009	WO2009134666A1 Indazole compounds as ccr1 receptor antagonists
11/05/2009	WO2009134400A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
11/05/2009	WO2009134392A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
11/05/2009	WO2009134387A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
11/05/2009	WO2009134384A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
11/05/2009	WO2009134383A2 Vinyl substituted fatty acids
11/05/2009	WO2009133905A1 Peptide capable of inhibiting activity of human fibroblast growth factor-23 (human fgf-23), and pharmaceutical composition comprising the same
11/05/2009	WO2009133861A1 Cyclic amine compound
11/05/2009	WO2009133831A1 Phenylpropionic acid derivative and use thereof
11/05/2009	WO2009133694A1 Bone strengthening food supplement
11/05/2009	WO2009133136A1 Compounds
11/05/2009	WO2009100107A3 Alendronate formulations, method of making and method of use thereof
11/05/2009	WO2009066283A3 Calcium-mediated effects of coral and methods of use thereof
11/05/2009	US20090275576 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-carboxamide derivatives, their preparation and therapeutic use
11/05/2009	US20090275557 Novel Composition for Treatment of Diseases Related to Activated Lymphocytes
11/05/2009	US20090275516 Compounds and method for modulating inflammatory reactions
11/05/2009	US20090275515 2-hydroxy-2-phenylthiophenylpropionamides as androgen receptor modulators
11/05/2009	US20090275501 Somatostatin-dopamine chimeric analogs
11/05/2009	US20090274736 Nutraceutical Compositions From Microalgae And Related Methods of Production And Administration
11/05/2009	US20090274717 Genes and proteins, and their use
11/05/2009	US20090274706 Antibodies to granulocyte-macrophage colony-stimulating factor
11/05/2009	US20090274703 Methods of treating inflammation using IL-17 antagonists
11/05/2009	US20090274695 Inhibition of urokinase-type plasminogen activator (uPA) activity
11/05/2009	US20090274688 Antibodies to OPGL
11/05/2009	US20090274627 Composition for Regeneration of Periodontal Soft Tissue and Method for Producing the Same
11/05/2009	CA2729053A1 Vinyl substituted fatty acids
11/05/2009	CA2723039A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
11/05/2009	CA2723034A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
11/05/2009	CA2723032A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
11/05/2009	CA2722923A1 Indazole compounds as ccr1 receptor antagonists
11/05/2009	CA2722671A1 Use of nucleic acids with reduced pressure therapy
11/05/2009	CA2722571A1 Pharmaceutical gallium compositions and methods
11/05/2009	CA2722427A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
11/05/2009	CA2722137A1 Antibodies to granulocyte-macrophage colony-stimulating factor
11/05/2009	CA2720647A1 Levels of april in serum and use in diagnostic methods
11/04/2009	EP2113518A1 Bone/cartilage formation-stimulating agent
11/04/2009	EP1610864B1 Electromagnetic stimulation in patients with osteoporosis
11/04/2009	EP1542716B1 Growth hormone releasing peptides
11/04/2009	EP1481077B1 Mitotic kinesin inhibitors
11/04/2009	EP1455773B1 2-aryl-propionic acids and pharmaceutical compositions containing them
11/04/2009	EP1432700B1 Spiro-hydantoin compounds useful as anti-inflammatory agents
11/04/2009	CN101570528A Glycyrrhizin derivatives and preparation and use thereof
11/04/2009	CN101569687A Herbal medicine for osteoporosis and related conditions
11/04/2009	CN101569682A Medical composition for treating rheumatoid arthritis and preparation method and quality control method thereof
11/03/2009	US7612238 Such as (R)-2-amino-2-methyl-4-[4-(4,4,5,5,5-pentafluoro-pentyloxy)-phenyl]-butan-1-ol hydrochloride for treatment of disorders or diseases mediated by lymphocytes, and for treating acute or chronic transplant rejection or T-cell-mediated inflammatory or autoimmune diseases
11/03/2009	US7612114 Selective estrogen receptor modulator
11/03/2009	US7612110 Immunosuppressants; for use in transplantation medicine or treatment of autoimmune diseases such as polyarthritis but not psoriatitc arthritis; micro-tablets, pellets
11/03/2009	US7612092 Nitrogen-containing aromatic derivatives
11/03/2009	US7612075 Anticaogulants; cardiovascular disorders
11/03/2009	US7612066 1-(3-tert-butyl-4-methoxy-5-morpholinophenyl)-2-(5,6-diethoxy-7-fluoro-1-imino-1,3-dihydroisoindol-2-yl)ethanone,; stabilizing the composition; not decompose even when placed under humidification conditions
11/03/2009	US7612050 Via bisphosphonate drug; for prophylaxis of cartilage destruction or chondrolysis associated with osteonecrosis and/or osteochondritis dissecans
11/03/2009	US7612034 Administering calcitonin and dehydroepiandrosterone (DHEA) to patient being treated for systemic lupus erythematosus where the immunosuppressant tends to reduce bone mineral density(BMD); osteoporosis
11/03/2009	US7611722 Reduced contact of the active ingredient in solid form with the mucosa lining the gastrointestinal tract, which is particularly advantageous for delivering an ulcerative drug.
11/03/2009	US7611708 Methods of therapy for B-cell malignancies using antagonist anti-CD40 antibodies
11/03/2009	CA2449729C Prodrugs of gaba analogs, compositions and uses thereof
10/2009
10/29/2009	WO2009131553A2 Methods of altering bone growth by administration of sost or wise antagonist or agonist
10/29/2009	WO2009131470A1 Compositions and methods for maintaining bone health or reducing bone loss
10/29/2009	WO2009131171A1 Novel five-membered ring compound
10/29/2009	WO2009131170A1 Five-membered ring compound
10/29/2009	WO2009131090A1 Amino acid compound
10/29/2009	WO2009131065A1 Long-chain fatty acid elongation enzyme inhibitor comprising arylsulfonyl derivative as active ingredient
10/29/2009	WO2009130317A1 1- (7-(hexahydropyrrolo [3, 4-c] pyrrol-2 (1h) -yl) quin0lin-4-yl) -3- (pyrazin-2-yl) urea derivatives and related compounds as glycogen synthase kinase 3 (gsk-3)
10/29/2009	WO2009130005A2 Preparation and use of a plant extract from solanum glaucophyllum with an enriched content of 1,25-dihydroxyvitamin d3 glycosides and quercetin glycosides
10/29/2009	WO2009129818A1 Preparation and use of a plant extract from solanum glaucophyllum with an enriched content of 1,25-dihydroxyvitamin d3 glycosides and quercetin glycosides
10/29/2009	WO2009102789A3 Use of rxr agonists for the treatment of osteroarthritis
10/29/2009	US20090270458 Method of treating of demyelinating diseases or conditions
10/29/2009	US20090270442 Polymorphs of hydrochloride salt of 5-(3-(ethylsulfonyl)phenyl)-3,8-dimethyl-n-(1-methylpiperidin-4-yl)-9h-pyrido[2,3-b]indole-7-carboxamide and methods of use therefor
10/29/2009	US20090270422 treating osteoporosis, rheumatoid arthritis, osteoarthritis, periodontal disease, alveolar bone loss, osteotomy bone loss, childhood idiopathic bone loss, Paget's disease, bone loss due to metastatic cancer, osteolytic lesions, using GPR119 agonist in combination with dipeptidyl peptidase IV inhibitor
10/29/2009	US20090270399 Novel pyridazine derivatives and medicines containing the same as effective ingredients
10/29/2009	US20090270395 EP4 Receptor Agonist, Compositions and Methods Thereof
10/29/2009	US20090270368 Angiogenesis inhibition by cephalotaxine alkaloids, derivatives, compositions and uses thereof
10/29/2009	US20090270324 Complement depletion using recombinant human c-3 derivatives
10/29/2009	US20090269840 Kinase insert domain-containing receptor (KDR) specific immunoglobulin for monitoring tumor angiogenesis
10/29/2009	US20090269410 Inhibition of Neovascularization by Cerium Oxide Nanoparticles
10/29/2009	US20090269400 Nanoparticulate and Controlled Release Compositions Comprising a Cephalosporin
10/29/2009	US20090269387 Composite implants for promoting bone regeneration and augmentation and methods for their preparation and use
10/29/2009	US20090269386 Composite implants for promoting bone regeneration and augmentation and methods for their preparation and use
10/29/2009	US20090269336 have a high binding affinity to all five isoforms of human vascular endothelial growth factor (VEGF); for cancer, age-related macular degeneration (AMD), rheumatoid arthritis, and diabetic retinopathy
10/29/2009	US20090269303 Method for treating or preventing conditions by elevation of the adenosine level in an individual
10/29/2009	US20090269302 Human antibodies that bind human il-12 and methods for producing
10/29/2009	DE202008008059U1 Zusammensetzung zur Prophylaxe und Therapie der Arthrose Composition for the prophylaxis and treatment of osteoarthritis
10/29/2009	DE102008020939A1 Preparing an extract e.g. for the regeneration of muscle tension, muscle-nerves and skin damage and scars and for the acceleration of wound healing, comprises extracting a body material of immunologically immature slaughtered animals
10/29/2009	CA2722075A1 Long-chain fatty acyl elongase inhibitor comprising arylsulfonyl derivative as active ingredient
10/29/2009	CA2722041A1 Novel five-membered ring compound
10/29/2009	CA2722007A1 Five-membered ring compound
10/29/2009	CA2721566A1 Preparation and use of a plant extract from solanum glaucophyllum with an enriched content of 1,25-dihydroxyvitamin d3 glycosides and quercetin glycosides
10/29/2009	CA2720659A1 1-(7-(hexahydropyrrolo[3,4-c]pyrrol-2(1h)-yl)quinolin-4-yl)-3-(pyrazin-2-yl)urea derivatives and related compounds as glycogen synthase kinase 3 (gsk-3)
10/28/2009	EP1976538B1 Pharmaceutical formulation for the treatment of osteoarthritis containing clodronic acid and hyaluronic acid

1 ... 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 ... 820